Ignite Creation Date:
2024-05-06 @ 8:11 AM
Last Modification Date:
2024-10-26 @ 11:57 AM
Study NCT ID:
NCT02681861
Status:
COMPLETED
Last Update Posted:
2017-01-10
First Post:
2016-01-21
Brief Title:
A Study to Assess the Safety Tolerability Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects
Sponsor:
Astellas Pharma Europe BV
Organization:
Astellas Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
None
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-21
First Submit QC Date:
February 10 2016
Study First Post Date:
2016-02-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-09
Last Update Post Date:
2017-01-10
Last Update Post Date Type:
ESTIMATED